Search the Newsreel

SGHT|Sight Sciences Inc|Price:5.300|Chg%:+0.180

TradingKey provides a comprehensive stock analysis of Sight Sciences Inc (SGHT), highlighting its strong fundamentals, significant growth potential, and "Buy" rating from multiple analysts with a target price of $9.00. The company,

UBS Adjusts Price Target on Sight Sciences to $7 From $11, Maintains Buy Rating

UBS has revised its price target for Sight Sciences (SGHT) to $7 from the previous $11, while opting to maintain a Buy rating on the stock. This adjustment reflects a change in the firm's outlook on the company's valuation.

Sight Sciences Inc (SGHT) Financial Health: Profitability & Balance Sheet Analysis

Sight Sciences Inc (SGHT) currently holds a financial score of 6.91, ranking 123 out of 199 in its industry, indicating robust financial health with average operating efficiency. The company recently reported a 12.51% year-over-year increase in quarterly revenue, reaching $19.70 million, and an 8.29% …

Sight Sciences Market Sentiment

The article provides an overview of market sentiment for Sight Sciences (SGHT), highlighting analyst consensus, short interest, and insider activity. Analysts have a "Buy" consensus with an average price target of $8, while insider activity indicates a "Net Seller" trend over the last 30 …

Sight Sciences Inc (SGHT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Sight Sciences Inc (SGHT). It lists the major individual and institutional shareholders, providing their proportion of holdings and recent changes. The report also categorizes shareholder types and tracks institutional shareholding over several quarters, showing overall trends in …

Sight Sciences to report Q2 financial results after market close

Sight Sciences has scheduled the release of its second-quarter 2026 financial results for August 5, 2026, after market close. Following the release, the company will host an earnings conference call at 1:30 p.m. PT (4:30 p.m. ET) on the same day. The webcast of …

Sight Sciences Inc (SGHT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Sight Sciences Inc (SGHT), detailing its business segments, regional revenue, and profit contribution. As of the publication date, relevant financial data for these categories have not been disclosed by the company. The page also includes current stock …

Sight Sciences, Inc. $SGHT Position Lessened by Walleye Capital LLC

Sight Sciences Inc (SGHT) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Sight Sciences Inc (SGHT), allowing users to evaluate its financial soundness. It presents data for operating, investing, and financing cash flows, along with changes in working capital and net income. The article …

Sight Sciences schedules results webcast for Aug. 5 at 4:30 p.m. ET

Sight Sciences (Nasdaq: SGHT) announced it will report its second-quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET, accessible via live and archived webcast on the Investors …

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

Sight Sciences, Inc. (NASDAQ: SGHT) is scheduled to release its financial results for the second quarter of 2026 on August 5, 2026. The company will host a conference call and webcast on the same day to discuss the results and provide a business update. …

Sight Sciences wins $34M patent ruling against Alcon

Sight Sciences has won a $34 million patent infringement ruling against Alcon relating to its ophthalmic surgical devices used for glaucoma treatment. A jury in Delaware found that Alcon's Hydrus Microstent infringed on Sight Sciences' patents. Shares of Sight Sciences surged over 40% following …

Sight Sciences Q1 2026 Earnings: EPS Misses Estimates, Stock Edges Higher - Annual Earnings Summary

Sight Sciences Inc. (SGHT) Nears Support as Shares Edge Lower - Profit Surge Picks

Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Sight Sciences, Inc. Q1 2026 Earnings Call Summary

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

Sight Sciences 10-K: Revenue $77.4M, EPS (0.74)

Sight Sciences Announces Medicare Pricing for TearCare® Procedure in Novitas and First Coast Jurisdictions

Sight Sciences Wins UnitedHealthcare Coverage for OMNI Glaucoma System, 30M Lives

Sight Sciences (SGHT) Stock Price, News & Analysis

Sight Sciences Inc (SGHT) News, Articles, Events & Latest Updates